Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases

CONCLUSIONS: The ALK-BPI is a reliable tool for easy prognostic dichotomization of TKI-treated ALK+ NSCLC patients with BM in daily clinical practice, without the complexity of previous …